ARCHIVES

NCI disclosure of walk-out by Data and Safety Monitoring Board of the National Lung Screening Trial may be harmful, improper, experts say.

This article is from The Cancer Letter archive.

Vol. 30 No. 16 | April 16, 2004

Download PDF Visit The Full Archive

Related Articles

Caterpillar In. Benefits Plan To Cover Entry On BMT trials

June 14, 1996

ONS Adopts Position Statement On Rehabilitation

May 5, 1989

Emerging Technologies: Company To Expand Program Studying Polymer Platinates

June 1, 2001

Top 42 CCOPs (According To Priority Scores) Identified; Present Budget Would Draw Payline At 230

April 3, 1987

NCI To Recompete Drug Discovery Groups In 2003 As Program Nears Its 20th Year

November 29, 2002

Two Doses of the Vaccine Cervarix Can Be As Effective As Three

September 30, 2011